Cite
HARVARD Citation
Vitazka, P. et al. (n.d.). 1373PIdentification of subjects with locally advanced lung cancer who are likely to respond to standard-of-care chemoradiotherapy by a longitudinal monitoring of circulating tumor DNA (ctDNA) using a comprehensive ultra-sensitive NGS assay. Annals of oncology. p. . [Online].